Mary Beth Harler, Head, Research & Autoimmunity at IGM Biosciences, Inc. (IGMS), sold 1,487 shares at $11.54 ($17K) on 2024-09-13, disclosed to the SEC on 2024-09-17.
Open-market sale of $17k IGMS by Head, Research & Autoimmunity. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IGMS | SELL | 2025-03-18 | $9K | — | Filing → |
| IGMS | SELL | 2024-12-18 | $13K | — | Filing → |
| IGMS | SELL | 2024-06-18 | $12K | — | Filing → |